US 11767367
Monoclonal antibody neo-201 for the treatment of human carcinomas
granted A61KA61K2039/505A61K38/05
Quick answer
US patent 11767367 (Monoclonal antibody neo-201 for the treatment of human carcinomas) held by PRECISION BIOLOGICS, INC. expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/05, A61K38/1725, A61K38/20